Literature DB >> 25963660

Regulation of MicroRNA 183 by Cyclooxygenase 2 in Liver Is DEAD-Box Helicase p68 (DDX5) Dependent: Role in Insulin Signaling.

Omar Motiño1, Daniel E Francés2, Rafael Mayoral3, Luis Castro-Sánchez1, María Fernández-Velasco4, Lisardo Boscá5, Carmelo García-Monzón6, Rocío Brea1, Marta Casado7, Noelia Agra8, Paloma Martín-Sanz9.   

Abstract

Cyclooxygenase (COX) catalyzes the first step in prostanoid biosynthesis and exists as two isoforms. COX-1 is a constitutive enzyme involved in physiological processes, whereas COX-2 is induced by a variety of stimuli. MicroRNAs (miRNAs) are noncoding RNAs that function as key posttranscriptional regulators of gene expression. Although it is known that COX-2 expression is regulated by miRNAs, there are no data regarding COX-2 involvement in miRNA regulation. Considering our previous results showing that COX-2 expression in hepatocytes protects against insulin resistance, we evaluated the role of COX-2 in the regulation of a specific set of miRNAs implicated in insulin signaling in liver cells. Our results provide evidence of the molecular basis for a novel function of COX-2 in miRNA processing. COX-2 represses miRNA 23b (miR-23b), miR-146b, and miR-183 expression in liver cells by increasing the level of DEAD-box helicase p68 (DDX5) through phosphatidylinositol 3-kinase (PI3K)/p300 signaling and by modulating the enzymatic function of the Drosha (RNase type III) complex through its physical association with DDX5. The decrease of miR-183 expression promotes protection against insulin resistance by increasing insulin receptor substrate 1 (IRS1) levels. These results indicate that the modulation of miRNA processing by COX-2 is a key event in insulin signaling in liver and has potential clinical implications for the management of various hepatic dysfunctions.
Copyright © 2015, American Society for Microbiology. All Rights Reserved.

Entities:  

Mesh:

Substances:

Year:  2015        PMID: 25963660      PMCID: PMC4475926          DOI: 10.1128/MCB.00198-15

Source DB:  PubMed          Journal:  Mol Cell Biol        ISSN: 0270-7306            Impact factor:   4.272


  54 in total

Review 1.  Prostaglandin E2 receptor distribution and function in the gastrointestinal tract.

Authors:  I Dey; M Lejeune; K Chadee
Journal:  Br J Pharmacol       Date:  2006-10-02       Impact factor: 8.739

2.  Cyclooxygenase 2 inhibition exacerbates palmitate-induced inflammation and insulin resistance in skeletal muscle cells.

Authors:  Teresa Coll; Xavier Palomer; Francisco Blanco-Vaca; Joan Carles Escolà-Gil; Rosa M Sánchez; Juan C Laguna; Manuel Vázquez-Carrera
Journal:  Endocrinology       Date:  2009-12-18       Impact factor: 4.736

3.  Cyclooxygenase-2 inhibition induces apoptosis signaling via death receptors and mitochondria in hepatocellular carcinoma.

Authors:  Michael A Kern; Anke M Haugg; Andreas F Koch; Tobias Schilling; Kai Breuhahn; Henning Walczak; Binje Fleischer; Christian Trautwein; Christoph Michalski; Henning Schulze-Bergkamen; Helmut Friess; Wolfgang Stremmel; Peter H Krammer; Peter Schirmacher; Martina Müller
Journal:  Cancer Res       Date:  2006-07-15       Impact factor: 12.701

4.  Modulation of microRNA processing by p53.

Authors:  Hiroshi I Suzuki; Kaoru Yamagata; Koichi Sugimoto; Takashi Iwamoto; Shigeaki Kato; Kohei Miyazono
Journal:  Nature       Date:  2009-07-23       Impact factor: 49.962

5.  Molecular mechanisms of insulin resistance in IRS-2-deficient hepatocytes.

Authors:  Angela M Valverde; Deborah J Burks; Isabel Fabregat; Tracey L Fisher; José Carretero; Morris F White; Manuel Benito
Journal:  Diabetes       Date:  2003-09       Impact factor: 9.461

6.  MiR-101 downregulation is involved in cyclooxygenase-2 overexpression in human colon cancer cells.

Authors:  Antonio Strillacci; Cristiana Griffoni; Pasquale Sansone; Paola Paterini; Giulia Piazzi; Giorgia Lazzarini; Enzo Spisni; Maria Abbondanza Pantaleo; Guido Biasco; Vittorio Tomasi
Journal:  Exp Cell Res       Date:  2008-12-24       Impact factor: 3.905

7.  COX-2 mediates hepatitis B virus X protein abrogation of p53-induced apoptosis.

Authors:  Alfred S L Cheng; Jun Yu; Paul B S Lai; Henry L Y Chan; Joseph J Y Sung
Journal:  Biochem Biophys Res Commun       Date:  2008-07-02       Impact factor: 3.575

8.  A feedback loop comprising lin-28 and let-7 controls pre-let-7 maturation during neural stem-cell commitment.

Authors:  Agnieszka Rybak; Heiko Fuchs; Lena Smirnova; Christine Brandt; Elena E Pohl; Robert Nitsch; F Gregory Wulczyn
Journal:  Nat Cell Biol       Date:  2008-07-06       Impact factor: 28.824

9.  Prostaglandin E2 receptors and COX enzymes in human hepatocellular carcinoma: role in the regulation of cell growth.

Authors:  Antonella Cusimano; Daniela Foderà; Nadia Lampiasi; Antonina Azzolina; Monica Notarbartolo; Lydia Giannitrapani; Natale D'Alessandro; Giuseppe Montalto; Melchiorre Cervello
Journal:  Ann N Y Acad Sci       Date:  2009-02       Impact factor: 5.691

10.  BRCA1 regulates microRNA biogenesis via the DROSHA microprocessor complex.

Authors:  Shinji Kawai; Atsuo Amano
Journal:  J Cell Biol       Date:  2012-04-09       Impact factor: 10.539

View more
  18 in total

Review 1.  Dgcr8 knockout approaches to understand microRNA functions in vitro and in vivo.

Authors:  Wen-Ting Guo; Yangming Wang
Journal:  Cell Mol Life Sci       Date:  2019-01-29       Impact factor: 9.261

Review 2.  The multiple functions of RNA helicases as drivers and regulators of gene expression.

Authors:  Cyril F Bourgeois; Franck Mortreux; Didier Auboeuf
Journal:  Nat Rev Mol Cell Biol       Date:  2016-06-02       Impact factor: 94.444

3.  Downregulation of RIKP by miR-200a promotes the invasive ability of esophageal cancer cells by upregulating the expression of LIN28 and MMP-14.

Authors:  Qiuyun Yu; Jinhua Dai; Zhankun Zhu; Haibo Shen
Journal:  Int J Clin Exp Pathol       Date:  2017-08-01

4.  Cyclooxygenase-2 induces neoplastic transformation by inhibiting p53-dependent oncogene-induced senescence.

Authors:  Hyeon Ju Lee; So Ra Kim; Yu-Jin Jung; Jeong A Han
Journal:  Sci Rep       Date:  2021-05-10       Impact factor: 4.379

5.  MicroRNA-7 mediates cross-talk between metabolic signaling pathways in the liver.

Authors:  Ragunath Singaravelu; Curtis Quan; Megan H Powdrill; Tyler A Shaw; Prashanth Srinivasan; Rodney K Lyn; Rhea C Alonzi; Daniel M Jones; Roxana Filip; Rodney S Russell; John P Pezacki
Journal:  Sci Rep       Date:  2018-01-10       Impact factor: 4.379

6.  Cyclooxygenase 2 in liver dysfunction and carcinogenesis: Facts and perspectives.

Authors:  Paloma Martín-Sanz; Marta Casado; Lisardo Boscá
Journal:  World J Gastroenterol       Date:  2017-05-28       Impact factor: 5.742

Review 7.  Exosomal MicroRNAs as Mediators of Cellular Interactions Between Cancer Cells and Macrophages.

Authors:  Yoojung Kwon; Misun Kim; Youngmi Kim; Hyun Suk Jung; Dooil Jeoung
Journal:  Front Immunol       Date:  2020-06-11       Impact factor: 7.561

8.  RNA helicase p68 inhibits the transcription and post-transcription of Pkd1 in ADPKD.

Authors:  Lu Zhang; Linda Xiaoyan Li; Julie Xia Zhou; Peter C Harris; James P Calvet; Xiaogang Li
Journal:  Theranostics       Date:  2020-07-09       Impact factor: 11.556

9.  Donor Graft MicroRNAs: A Newly Identified Player in the Development of New-onset Diabetes After Liver Transplantation.

Authors:  Q Ling; H Xie; J Li; J Liu; J Cao; F Yang; C Wang; Q Hu; X Xu; S Zheng
Journal:  Am J Transplant       Date:  2016-09-07       Impact factor: 8.086

10.  The RNA helicase DDX17 controls the transcriptional activity of REST and the expression of proneural microRNAs in neuronal differentiation.

Authors:  Marie-Pierre Lambert; Sophie Terrone; Guillaume Giraud; Clara Benoit-Pilven; David Cluet; Valérie Combaret; Franck Mortreux; Didier Auboeuf; Cyril F Bourgeois
Journal:  Nucleic Acids Res       Date:  2018-09-06       Impact factor: 16.971

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.